Data compiled by Redley Lamar · ChainSifter Intelligence
0Suppliers
6Customers
3Debt Items
20Related Chains
Source-Backed Evidence Depth
Verastem, Inc. (VSTM) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
10Total relationships
2Distinct source URLs
5High confidence
0.782Average confidence
2026-09-14Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Verastem, Inc. Suppliers
No suppliers on recordVerastem, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.
Verastem, Inc. Customers
Ticker
Name
Confidence
Evidence
PANCREATIC-CANCER-NETWORK
PANCREATIC-CANCER-NETWORK
92%
For the three months ended March 31, 2026, there were two customers who each individually accounted for greater than 10% of the Company’s total revenues. These two customers accounted for revenues of…
SNYNF
Sanofi
72%
cell lymphoma and a payment of $ million upon receipt of the first regulatory approval for the commercial sale of COPIKTRA in the European Union for the treatment of peripheral T-cell lymphoma, (ii) …
SNYNF
Sanofi
72%
Reciprocal relationship from SNYNF graph: Reciprocal relationship from VSTM graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from VSTM graph: cell lymphoma and a payment of $ …
AFCO-PREMIUM-CREDIT-LLC
AFCO-PREMIUM-CREDIT-LLC
62%
ase rent amount was approximately $ 0.7 million, which increased during the lease term to $ 1.1 million for the last 12-month period. Effective November 1, 2024, the Company amended the February 2018…
